Related Experiment Video
Updated: Aug 27, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Immune Evasion of SARS-CoV-2 Omicron Subvariants
Hanzhong Ke1,2, Matthew R Chang1, Wayne A Marasco1,2
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.
Abstract:
Since the SARS-CoV-2 Omicron variant (B.1.1.529) was declared a variant of concern (VOC) by the WHO on 24 November 2021, it has caused another global surge of cases. With extensive mutations in its spike glycoprotein, Omicron gained substantial capabilities to evade the antiviral immunity provided by vaccination, hybrid immunity, or monoclonal antibodies. The Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 extended this immune evasion capability by having additional unique mutations in their respective spike proteins. The ongoing Omicron wave and emergence of new Omicron subvariants leads to additional concerns regarding the efficacy of the current antiviral measurements. To have a better understanding of the Omicron subvariants, this review summarizes reports of the immune evasion of subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 as well as the molecular basis of immune evasion.
Insights
The Omicron variant of SARS-CoV-2 and its subvariants (BA.1, BA.2, BA.2.12.1, BA.4, BA.5) show increased immune evasion due to spike protein mutations. This impacts current antiviral strategies against COVID-19.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- The SARS-CoV-2 Omicron variant (B.1.1.529) emerged as a global concern due to rapid case surges.
- Omicron possesses extensive spike glycoprotein mutations, enhancing its ability to evade existing immunity.
Purpose of the Study:
- To review the immune evasion properties of Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5.
- To elucidate the molecular mechanisms underlying the immune evasion of these Omicron subvariants.
Main Methods:
- Literature review of published reports on Omicron subvariant immune evasion.
- Analysis of molecular data related to spike protein mutations in Omicron subvariants.
Main Results:
- Omicron subvariants exhibit significant immune evasion capabilities.
- Additional mutations in BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 further enhance immune escape.
- The molecular basis for this enhanced evasion is linked to specific spike protein alterations.
Conclusions:
- Omicron subvariants pose ongoing challenges to the effectiveness of current antiviral measures.
- Understanding the molecular basis of immune evasion is crucial for developing future COVID-19 countermeasures.
More Related Videos
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Subviral Agents
Viruses with RNA Genomes
Single Nucleotide Polymorphisms-SNPs
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

